These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats. Leong ZP; Hikasa Y Vascul Pharmacol; 2018 Nov; 110():31-41. PubMed ID: 30071297 [TBL] [Abstract][Full Text] [Related]
3. Reversal effects of low-dose imatinib compared with sunitinib on monocrotaline-induced pulmonary and right ventricular remodeling in rats. Leong ZP; Okida A; Higuchi M; Yamano Y; Hikasa Y Vascul Pharmacol; 2018 Jan; 100():41-50. PubMed ID: 29100963 [TBL] [Abstract][Full Text] [Related]
4. Combined tyrosine and serine/threonine kinase inhibition by sorafenib prevents progression of experimental pulmonary hypertension and myocardial remodeling. Klein M; Schermuly RT; Ellinghaus P; Milting H; Riedl B; Nikolova S; Pullamsetti SS; Weissmann N; Dony E; Savai R; Ghofrani HA; Grimminger F; Busch AE; Schäfer S Circulation; 2008 Nov; 118(20):2081-90. PubMed ID: 18955668 [TBL] [Abstract][Full Text] [Related]
5. Pulmonary artery banding is a relevant model to study the right ventricular remodeling and dysfunction that occurs in pulmonary arterial hypertension. Akazawa Y; Okumura K; Ishii R; Slorach C; Hui W; Ide H; Honjo O; Sun M; Kabir G; Connelly K; Friedberg MK J Appl Physiol (1985); 2020 Aug; 129(2):238-246. PubMed ID: 32644912 [TBL] [Abstract][Full Text] [Related]
6. Early versus late cardiac remodeling during right ventricular pressure load and impact of preventive versus rescue therapy with endothelin-1 receptor blockers. Ramos SR; Pieles G; Sun M; Slorach C; Hui W; Friedberg MK J Appl Physiol (1985); 2018 May; 124(5):1349-1362. PubMed ID: 29446710 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin Receptor-Neprilysin Inhibition Attenuates Right Ventricular Remodeling in Pulmonary Hypertension. Sharifi Kia D; Benza E; Bachman TN; Tushak C; Kim K; Simon MA J Am Heart Assoc; 2020 Jul; 9(13):e015708. PubMed ID: 32552157 [TBL] [Abstract][Full Text] [Related]
8. 17β-estradiol preserves right ventricular function in rats with pulmonary arterial hypertension: an echocardiographic and histochemical study. Wang YD; Li YD; Ding XY; Wu XP; Li C; Guo DC; Shi YP; Lu XZ Int J Cardiovasc Imaging; 2019 Mar; 35(3):441-450. PubMed ID: 30350115 [TBL] [Abstract][Full Text] [Related]
9. Tyrosine kinase inhibitor BIBF1000 does not hamper right ventricular pressure adaptation in rats. de Raaf MA; Herrmann FE; Schalij I; de Man FS; Vonk-Noordegraaf A; Guignabert C; Wollin L; Bogaard HJ Am J Physiol Heart Circ Physiol; 2016 Sep; 311(3):H604-12. PubMed ID: 27342880 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological Inhibition of mTOR Kinase Reverses Right Ventricle Remodeling and Improves Right Ventricle Structure and Function in Rats. Pena A; Kobir A; Goncharov D; Goda A; Kudryashova TV; Ray A; Vanderpool R; Baust J; Chang B; Mora AL; Gorcsan J; Goncharova EA Am J Respir Cell Mol Biol; 2017 Nov; 57(5):615-625. PubMed ID: 28679058 [TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase inhibitors are potent acute pulmonary vasodilators in rats. Abe K; Toba M; Alzoubi A; Koubsky K; Ito M; Ota H; Gairhe S; Gerthoffer WT; Fagan KA; McMurtry IF; Oka M Am J Respir Cell Mol Biol; 2011 Oct; 45(4):804-8. PubMed ID: 21378262 [TBL] [Abstract][Full Text] [Related]